A User Guide: National Statement on Ethical Conduct in Human Research (2007) - Updated 2018
This National Statement on Ethical Conduct in Human Research (‘National Statement’) is intended for use by:
• any researcher conducting research with human participants;
• any member of an ethical review body reviewing that research;
• those involved in research governance;
and
• potential research participants.
This brief guide describes the structure of the document and suggests how each of these groups might use it. Note that ‘review body’ refers both to Human Research Ethics Committees (HRECs) and to non-HREC review bodies.
The Preamble sets out the historical context of the National Statement. This is followed by a brief explanation of its purpose, scope and limits. The document then has five sections, with multiple chapters in Sections 2 to 5.
• Section 1: Values and principles of ethical conduct sets out values and principles that apply to all human research. It is essential that researchers and review bodies consider these values and principles and be satisfied that the research proposal addresses and reflects them.
• Section 2: Themes in research ethics: risk and benefit, consent discusses the concept of risk in research and the role of participants’ consent – themes in all human research – and is again essential for all users.
Chapter 2.1 will help researchers and reviewers to understand and describe
the level of risk involved in the planned research, and how to minimise, justify and manage that risk, and (with reference to Chapter 5.1) what level of ethical review is suitable.
Chapters 2.2 and 2.3 will help to identify the information that needs to be disclosed to participants. It will help researchers to draft information for
participants and plan the consent process (or develop a proposal for waiver of consent). And it will help reviewers to assess the suitability of the proposed consent process.
All of Section 2 will help participants understand what information they are entitled to receive, and what their participation in research will characteristically involve.
• Section 3: Ethical considerations in the design, development, review and
conduct of research will help researchers and reviewers to identify ethical matters specific to the research methods proposed.
• Section 4: Ethical considerations specific to participants will help researchers and reviewers to identify ethical matters relating to specific categories of research participants. Participants in these categories will also find this Section valuable.
• Section 5: Processes of research governance and ethical review will help those involved in research governance to understand their responsibilities for research ethics and ethical review and monitoring of human research, and provides criteria for their accountability. Chapter 5.2 will help researchers and reviewers to identify their responsibilities in relation to the ethical review of research.
This National Statement does not exhaust the ethical discussion of human research. Even a single research field covers a multitude of different situations about which the National Statement will not always offer specific
guidance, or to which its application may be uncertain. Where other guidelines and codes of practice in particular research fields are consistent with the National Statement, researchers and members of ethical review bodies should draw on them when necessary to clarify researchers’ ethical obligations in particular contexts.
Authors of this National Statement
This National Statement has been jointly developed by the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC) and Universities Australia (UA). This joint undertaking reflects a widely shared conviction that there is a need for ethical guidelines that are genuinely applicable to all human research and it gives expression to the shared responsibility for ethically good research described above.
Clinical Research News
Kommende kliniske studier
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Har ikke rekruttert ennåIkke-småcellet lungekreftKina
-
RenJi HospitalChanghai Hospital; First People's Hospital of Hangzhou; West China Hospital; Chengdu University of Traditional Chinese Medicine og andre samarbeidspartnereHar ikke rekruttert ennå
-
RenJi HospitalChanghai Hospital; First People's Hospital of Hangzhou; West China Hospital; Chengdu University of Traditional Chinese Medicine og andre samarbeidspartnereRekruttering
-
CSPC Megalith Biopharmaceutical Co.,Ltd.Har ikke rekruttert ennå
-
Foundation EndourologyThe International Alliance of UrolithiasisRekruttering
-
Istanbul Galata UniversityThe Scientific and Technological Research Council of TurkeyHar ikke rekruttert ennåSystemisk Lupus Erythematosus(SLE)Tyrkia (Türkiye)
-
Postgraduate Institute of Dental Sciences RohtakRekruttering
-
Prof Ibrahim JanahiHar ikke rekruttert ennåObesity-associated AsthmaQatar
-
Sohag UniversityHar ikke rekruttert ennåParkinsons sykdom
-
Greater Atlanta Integrative PediatricsRekrutteringAutismespektrumforstyrrelse | Autisme | ASD | Autismespektrumforstyrrelse (ASD)Forente stater
-
The General Hospital of Western Theater CommandHar ikke rekruttert ennåThrombocytopenic Purpura, Immune
-
Guangdong Hengrui Pharmaceutical Co., LtdHar ikke rekruttert ennåGeneralisert myasthenia gravisKina
Clinical Research Jobs
-
Philippines - Quezon City
-
United States - Ohio - Cincinnati
-
United States - Reno
-
China
-
United States - North Carolina - Durham
-
Romania - Bucharest
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China